Pathology: MIBC - NA - all population; MIBC - NA - PDL1 positive;
| MIBC - NA - all population | MIBC - NA - PDL1 positive | |||
| IMvigor-010, 2021 | CheckMate 274 (all population), 2017 | CheckMate 274 (PDL1>1%), 2017 | ||
| nivolumab alone | 2 | T1 | T1 | |
| atezolizumab alone | 1 | T1 | ||
| no additional treatment | 0 | T0 | ||
| placebo | 0 | T0 | T0 | |